Amneal Pharmaceuticals (AMRX) Retained Earnings (2017 - 2026)
Amneal Pharmaceuticals (AMRX) posted quarterly Retained Earnings of $536.3 million for Q1 2026, up 725.49% year-over-year from $65.0 million in Q1 2025, and up 200.24% quarter-over-quarter from -$535.0 million in Q4 2025.
Amneal Pharmaceuticals (AMRX) Retained Earnings (2017 - 2026) Analysis & Trends
Amneal Pharmaceuticals' Retained Earnings history runs 10 years deep, the most recent figure standing at $536.3 million for Q1 2026.
- In Q1 2026, Retained Earnings rose 725.49% year-over-year to $536.3 million; the TTM figure through Mar 2026 stood at $536.3 million (up 725.49% YoY), while the FY2025 annual figure was -$535.0 million, up 11.87% from the prior year.
- Retained Earnings for Q1 2026 stood at $536.3 million, up from -$535.0 million in the prior quarter.
- The five-year high for Retained Earnings was $700.7 million in Q1 2023, with the low at -$607.1 million in Q4 2024.
- The 5-year median for Retained Earnings is -$23.7 million (2024), against an average of -$10.5 million.
- The sharpest annual moves came in 2023 and 2024: Retained Earnings soared 200879.94% in 2023, then tumbled 7223.9% in 2024.
- Amneal Pharmaceuticals' Retained Earnings stood at $9.9 million in 2022, then plunged by 425.48% to -$32.3 million in 2023, then tumbled by 1776.6% to -$607.1 million in 2024, then climbed by 11.87% to -$535.0 million in 2025, then surged by 200.24% to $536.3 million in 2026.
- Business Quant data shows AMRX's Retained Earnings at $536.3 million in Q1 2026, -$535.0 million in Q4 2025, and $563.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 3.75 Bn |
| 10 | Amneal Pharmaceuticals | 5.70 Bn | 5.57 Bn | 334.51 Mn | 545.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 545.58 Mn |
| Mar 31, 2026 | 536.30 Mn |
| Dec 31, 2025 | -535.01 Mn |
| Sep 30, 2025 | 563.36 Mn |
| Jun 30, 2025 | -572.45 Mn |
| Mar 31, 2025 | -85.74 Mn |
| Dec 31, 2024 | -607.06 Mn |
| Sep 30, 2024 | 553.23 Mn |
| Jun 30, 2024 | -575.83 Mn |
| Mar 31, 2024 | -23.71 Mn |
| Dec 31, 2023 | -32.35 Mn |
| Sep 30, 2023 | -391.53 Mn |
| Jun 30, 2023 | 8.08 Mn |
| Mar 31, 2023 | 700.72 Mn |
| Dec 31, 2022 | 9.94 Mn |
| Sep 30, 2022 | -401.85 Mn |
| Jun 30, 2022 | 675.59 Mn |
| Mar 31, 2022 | -349,000.00 |
| Dec 31, 2021 | -276.20 Mn |
| Sep 30, 2021 | 650.54 Mn |